Tuesday, March 17, 2026

Why Singapore’s Capella Hotel is a Historic Venue for Peace Talks Between Korea and the U.S.

President Lee Jae Myung praises Singapore's role in diplomacy during a state dinner, highlighting mutual interests and cultural ties.

Kim Jong-un Sends New Year Greeting To Putin: “The Most Sincere Alliance Relationship”

Kim Jong Un sends New Year's greetings to Putin, highlighting the strong North Korea-Russia alliance and commitment to future cooperation.

How AI’s Role in Warfare Reflects the Perils of Martial Law Without Oversight

Critics warn of unchecked power, drawing parallels between South Korea’s martial law and the risks of AI systems.

Tag: Patent

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Rokit Healthcare Secures UAE Patent for AI-Based Cartilage Regeneration: A Game-Changer in Middle Eastern Joint Treatment

Rokit Healthcare secures a UAE patent for AI cartilage regeneration, targeting a $682M market and shifting focus to regenerative medicine.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.